Filing Details
- Accession Number:
- 0001209191-15-020496
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-02 19:20:46
- Reporting Period:
- 2015-02-27
- Filing Date:
- 2015-03-02
- Accepted Time:
- 2015-03-02 19:20:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1108109 | Community Health Systems Inc | CYH | Services-General Medical & Surgical Hospitals, Nec (8062) | 133893191 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1217259 | T Michael Portacci | 4000 Meridian Boulevard Franklin TN 37067 | Division President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-27 | 50,000 | $40.41 | 86,210 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-02-27 | 50,000 | $48.56 | 36,210 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-02-27 | 3,496 | $48.52 | 32,714 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2015-03-01 | 25,000 | $0.00 | 57,714 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-03-01 | 3,333 | $0.00 | 61,047 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-03-01 | 4,895 | $48.52 | 56,152 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2015-02-27 | 50,000 | $0.00 | 50,000 | $40.41 |
Common Stock | Performance Based Restricted | Disposition | 2015-03-01 | 25,000 | $0.00 | 25,000 | $0.00 |
Common Stock | Performance Based Restricted | Disposition | 2015-03-01 | 3,333 | $0.00 | 3,333 | $0.00 |
Common Stock | Performance Based Restricted | Acquisiton | 2015-03-01 | 35,000 | $0.00 | 35,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2008-07-25 | 2015-07-24 | No | 4 | M | Direct |
0 | 2015-03-01 | 2024-02-29 | No | 4 | M | Direct |
6,667 | 2015-03-01 | 2024-02-29 | No | 4 | M | Direct |
35,000 | 2016-03-01 | 2025-02-28 | No | 4 | A | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | $32.28 | 2009-02-27 | 2018-02-26 | 20,000 | 20,000 | Direct |
Common Stock | Stock Options (Right to Buy) | $33.90 | 2011-02-24 | 2020-02-23 | 10,000 | 10,000 | Direct |
Common Stock | Stock Options (Right to Buy) | $37.96 | 2012-02-23 | 2021-02-22 | 10,000 | 10,000 | Direct |
Common Stock | Stock Options (Right to Buy) | $21.07 | 2013-02-16 | 2022-02-15 | 2,667 | 2,667 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2018-02-26 | 20,000 | 20,000 | Direct |
2020-02-23 | 10,000 | 10,000 | Direct |
2021-02-22 | 10,000 | 10,000 | Direct |
2022-02-15 | 2,667 | 2,667 | Direct |
Footnotes
- The shares were sold in a series of transactions at a weighted average price of $48.5601 per share.
- The performance objectives governing these shares of Performance Based Restricted Stock have been met, and, accordingly, these shares will now be reported in Table 1 as directly owned shares of Restricted Stock. The restrictions lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
- Each performance based restricted share represents a contingent right to receive one share of CYH common stock. The Company has achieved the cost savings ("synergies") from the Health Management Associates, Inc. ("HMA") merger transaction that were required to be achieved during the first year following the merger transaction, and, accordingly, 1/3 of the performance based restricted shares awarded in conjunction with the completion of the HMA merger transaction will now be reported on Table 1 as directly owned shares. The restrictions on such shares have lapsed. The remaining 2/3 of the performance based restricted shares awarded in conjunction with the completion of the HMA merger transaction will remain subject to the two-year performance target, which may be met in whole or in part in the second year following the grant. There is also a time vesting element to the maximum targets of the award. If the objectives are not met, the shares will be forfeited.